APrf Lyndsey Collins-Praino

Associate Professor

School of Pharmacy and Biomedical Science

College of Health


A/Professor Lyndsey Collins-Praino leads the Cognition, Ageing and Neurodegenerative Disease Laboratory (CANDL) and is Chair of the Research Committee for the School of Biomedicine. She holds a PhD in behavioral neuroscience from the University of Connecticut and completed a post-doctoral fellowship in cognitive neuroscience at Columbia University Medical Centre. After re-locating to Australia in 2014, she founded and currently leads CANDL, where she and her team take a bench-to-bedside approach to identify biomarkers that predict risk and progression of cognitive decline in healthy ageing and neurological conditions, such as Parkinson’s disease, traumatic brain injury and dementia. She is passionate about earlier identification of neurodegenerative disease risk for improved diagnosis/prognosis and more targeted therapeutic intervention, and is an advocate for improved incorporation of evidence-based biomarkers into neurological practice. She has published >80 high impact publications and has received more than AUD$11 million in competitive research funding from both Category 1 (MRFF, NHMRC, ARC) and philanthropic sources. She has been the recipient of numerous prestigious research awards, including a 2016 South Australian Young Tall Poppy award (Finalist, Tall Poppy of the Year), and her research can be seen featured in multiple media outlets.A/Prof Collins-Praino in an enthusiastic advocate for bringing together scientists and consumers with government, industry and philanthropic partners to improve research translation/impact and influence patient care. She is also committed to meaningful incorporation of "lived experience" perspectives into ageing and neurological disease research and routinely engages with stakeholders through focus groups and co-design, as well as educational talks to patient support groups. She pairs this with demonstrated excellence in science communication and media engagement to raise public awareness of neurodegenerative disease and promote healthy brain ageing. She is a frequent organiser of and participant in science outreach events at diverse events in both metro and regional locations, including Science Alive, National Science Week, the Museum of Discovery (MOD), Science in the Pub and the Adelaide Fringe Festival.In addition, A/Prof Collins-Praino is also a nationally award winning neuroscience educator, curriculum designer and HDR/Honours supervisor, focused on training the next generation of excellence in brain science. Her outstanding teaching has been recognised through numerous teaching awards at the University (every teaching award offered by the Faculty or University, including the University Outstanding Achievement Award for Excellence in Teaching, 2020), as well as at both the state (SA Early Career STEM Educator of the Year, Tertiary Education, 2016) and national (National Citation for Outstanding Contribution to Student Learning, Australian Awards for University Teaching, 2020) level. In 2024, her excellence in supervisory practice was recognised with a University Commendation for Implementing Effective HDR Supervisory Practices.

I am the Head of the Cognition, Ageing and Neurodegenerative Disease laboratory (CANDL). Within CANDL, our research utilises an innovative "dish to deathbed" approach to identify novel predictors of the risk/rate of cognitive decline both in healthy ageing and in neurodegenerative diseases, such as Alzheimer's and Parkinson's disease. We are particularly interested on the role of neuroinflammation in this process.  

Currently, there are a number of projects ongoing. Some of these include

1. Investigation of whether targeting aberrant neuroinflammation can improve functional outcomes and slow dopamine neuron degeneration in pre-clinical models of Parkinson's disease.

2. Identification of novel methods to prevent the spread of pathological proteins in neurodegenerative disease.

3. Investigation of whether growth factor administration is able to prevent neurodegeneration and reduce chronic inflammation following traumatic brain injury.

4. Use of novel genomic analyses and cognitive data to predict risk and rate of cognitive decline in healthy ageing and Parkinson's disease.

5. Investigation of whether a neuroinflammatory signature is predictive of conversion to dementia in Parkinson's disease.

6. Assessment of the role of microglia in pathological transmission of alpha synuclein.

7. Use of cognitive training to improve cognitive function in Parkinson's disease.

8. Tracking the evolution of parkinsonian like-pathology following traumatic brain injury.

Date Position Institution name
2020 - ongoing Associate Professor University of Adelaide
2017 - 2019 Senior Lecturer University of Adelaide
2014 - 2016 Lecturer University of Adelaide

Date Type Title Institution Name Country Amount
2016 Award Early Career STEM Educator of the Year (Tertiary Teaching) - - -
2016 Award Executive Dean's Award for Teaching Excellence - - -
2016 Fellowship International Neurotrauma Symposium travel fellowship - - -
2016 Award South Australian Young Tall Poppy (Finalist, Tall Poppy of the Year) - - -
2015 Award Unsung euro of South Australian Science, Finalist - - -
2012 Fellowship Society for Neuroscience/Japanese Neuroscience Society Travel Award - - -
2012 Fellowship Alzheimer’s Disease International Conference travel fellowship - - -
2012 Award Henry Taub Award for Best Poster Presentation Columbia University Medical Centre United States -
2012 Fellowship NIA Butler-Williams Scholar - - -
2010 Award Outstanding Scientific Presentation University of Connecticut Health Center United States -
2010 Award Tieman Research Prize NEURON Conference - -
2010 Fellowship Society for Neuroscience Graduate Student Travel Award - - -
2010 Fellowship International Basal Ganglia Society travel fellowship - - -
2006 Award Excellence in Neuroscience University of Scranton United States -

Language Competency
English Can read, write, speak, understand spoken and peer review
Italian Can read, write, speak and understand spoken

Date Institution name Country Title
University of Connecticut United States PhD
University of Connecticut United States MA
University of Connecticut United States Graduate Certificate
University of Scranton United States BS (Hons)

Date Title Institution Country
Post-doctoral Fellow Columbia University Medical Center United States

Year Citation
2025 Haller, O. J., Semendric, I., Collins-Praino, L. E., Whittaker, A. L., & George, R. P. (2025). Changes in cognition and astrocytic reactivity in a female rodent model of chemotherapy-induced cognitive impairment are variable both acutely and chronically. Behavioural Brain Research, 480, 115391-1-115391-15.
DOI Scopus1 WoS1 Europe PMC1
2025 Edwards, S., Corrigan, F., & Collins-Praino, L. (2025). Lasting Impact: Exploring the Brain Mechanisms that Link Traumatic Brain Injury to Parkinson’s Disease. Molecular Neurobiology, 62(6), 7421-7444.
DOI
2025 Rennie, C., Morshed, N., Faria, M., Collins-Praino, L., & Care, A. (2025). Nanoparticle Association with Brain Cells Is Augmented by Protein Coronas Formed in Cerebrospinal Fluid. Molecular Pharmaceutics, 22(2), 940-957.
DOI Scopus3 Europe PMC2
2025 Foreman, L., Child, B., Saywell, I., Collins-Praino, L., & Baetu, I. (2025). Cognitive reserve moderates the effect of COVID-19 on cognition: A systematic review and meta-analysis of individual participant data. Neuroscience and Biobehavioral Reviews, 171, 31 pages.
DOI Scopus1 WoS2 Europe PMC2
2025 Stuckey, S. M., Hood, R. J., Ong, L. K., Bilecki, I. M., Collins-Praino, L. E., & Turner, R. J. (2025). Unravelling the nexus of stroke and dementia: Deciphering the role of secondary neurodegeneration in orchestrating cognitive decline. Neuroprotection, 3(1), 5-28.
DOI
2025 McNamara, A., Baetu, I., & Collins-Praino, L. (2025). History of Traumatic Brain Injury Does Not Influence Rate of Progression of Clinical or Pathological Outcomes in Two Early Parkinson's Disease Cohorts.. Eur J Neurol, 32(3), e70090.
DOI
2025 Semendric, I., Barker, T. H., Haller, O. J., Pollock, D., Collins-Praino, L. E., & Whittaker, A. (2025). Prevalence of cancer-related cognitive impairment in pediatric patients and survivors: a systematic review and meta-analysis. Neuroscience and Biobehavioral Reviews, 176, 106283-1-106283-33.
DOI WoS1 Europe PMC1
2025 Carr, L., Mustafa, S., & Collins-Praino, L. E. (2025). The Hallmarks of Ageing in Microglia. Cellular and Molecular Neurobiology, 45(1), 38 pages.
DOI Scopus9 WoS11 Europe PMC10
2025 Ellul, B., McNamara, A., Laurenz, S., Baetu, I., Jenkinson, M., & Collins-Praino, L. E. (2025). Predicting Cognition and Affective Changes in Newly Diagnosed Parkinson’s Disease Through Longitudinal Data-Driven Clustering. Journal of Geriatric Psychiatry and Neurology, 17 pages.
DOI Scopus1 WoS1 Europe PMC1
2025 Carr, L. M., Guglietti, B., Wee, I. C., Musgrave, I. F., Mustafa, S., Corrigan, F., & Collins-Praino, L. E. (2025). Comparison of automated and manual approaches for microglial quantification and classification: A focus on the HALO digital pathology platform. Brain Pathology, 36(1), 17 pages.
DOI
2025 Salim, M. W., Zhang, W., Thae Hnit, S. S., Kamath, K. S., Collins-Praino, L. E., Care, A., & Wang, Y. (2025). Harvest Time-Dependent Changes in the Composition and Function of Microglia-Derived Small Extracellular Vesicles.. ACS Biomater Sci Eng, 11(10), 6150-6165.
DOI
2025 Homes-Vickers, M. A., Hobbs, D. A., Leonard, A. V., & Collins-Praino, L. E. (2025). Effectiveness of non-pharmacological interventions for cognitive impairment in Parkinson’s disease: systematic review protocol. Bjpsych Open, 11(6), 6 pages.
DOI
2025 McNamara, A., Ellul, B. P., Baetu, I., Jenkinson, M., Lau, S., & Collins-Praino, L. (2025). Utility of Baseline Pathological, Neuroimaging and Clinical Markers for Prognosis in Early Parkinson's Disease.. J Geriatr Psychiatry Neurol, 8919887251397641.
DOI
2025 Child, B., Beu, N., Saywell, I., da Silva, R., Collins-Praino, L., & Baetu, I. (2025). Cognitive function in different motor subtypes of Parkinson's disease: A systematic review and multilevel meta-analysis.. Cognitive, affective & behavioral neuroscience.
DOI
2024 McKimmie, A., Keeves, J., Gadowski, A., Bagg, M. K., Antonic-Baker, A., Hicks, A. J., . . . Teague, W. J. (2024). The Australian Traumatic Brain Injury Initiative: Systematic Review of Clinical Factors Associated with Outcomes in People with Moderate-Severe Traumatic Brain Injury. Neurotrauma Reports, 5(1), 640-659.
DOI Scopus2
2024 Green, A. L., Cowell, E. C., Carr, L. M., Hemsley, K., Sherratt, E., Collins-Praino, L. E., & Carr, J. M. (2024). Application of diceCT to Study the Development of the Zika Virus-Infected Mouse Brain. Viruses, 16(8), 1330-1-1330-19.
DOI
2024 Morshed, N., Rennie, C., Deng, W., Collins-Praino, L. E., & Care, A. (2024). Serum-derived Protein Coronas Affect Nanoparticle Interactions with Brain Cells.. Nanotechnology, 35(49), 15 pages.
DOI Scopus1 WoS2 Europe PMC1
2024 Guglietti, B., Mustafa, S., Corrigan, F., & Collins-Praino, L. E. (2024). Anatomical distribution of Fyn kinase in the human brain in Parkinson's disease.. Parkinsonism Relat Disord, 118, 105957.
DOI Scopus3 WoS2 Europe PMC1
2024 Bhattacharjee, R., Jolly, L. A., Corbett, M. A., Wee, I. C., Rao, S. R., Gardner, A. E., . . . Gecz, J. (2024). Compromised transcription-mRNA export factor THOC2 causes R-loop accumulation, DNA damage and adverse neurodevelopment. Nature Communications, 15(1), 1210-1-1210-5.
DOI Scopus11 WoS10 Europe PMC8
2024 Rennie, C., Sives, C., Boyton, I., Diaz, D., Gorrie, C., Vittorio, O., . . . Care, A. (2024). In Vivo Behavior of Systemically Administered Encapsulin Protein Nanocages and Implications for their use in Targeted Drug Delivery. Advanced Therapeutics, 7(2).
DOI Scopus12
2024 Boyton, I., Valenzuela, S. M., Collins-Praino, L. E., & Care, A. (2024). Neuronanomedicine for Alzheimer's and Parkinson's disease: Current progress and a guide to improve clinical translation.. Brain, behavior, and immunity, 115, 631-651.
DOI Scopus11 WoS11 Europe PMC6
2024 Amro, Z., Collins-Praino, L. E., & Yool, A. J. (2024). Protective roles of peroxiporins AQP0 and AQP11 in human astrocyte and neuronal cells in response to oxidative and inflammatory stressors.. Biosci Rep, 44(3), 21 pages.
DOI Scopus10 WoS11 Europe PMC10
2024 Wee, I. C., Arulsamy, A., Corrigan, F., & Collins-Praino, L. (2024). Long-Term Impact of Diffuse Traumatic Brain Injury on Neuroinflammation and Catecholaminergic Signaling: Potential Relevance for Parkinson’s Disease Risk. Molecules, 29(7), 1470.
DOI Scopus5 WoS5 Europe PMC6
2024 Gabbe, B. J., Keeves, J., Mckimmie, A., Gadowski, A. M., Holland, A. J., Semple, B. D., . . . Honeybul, S. (2024). The Australian Traumatic Brain Injury Initiative: Systematic Review and Consensus Process to Determine the Predictive Value of Demographic, Injury Event, and Social Characteristics on Outcomes for People With Moderate-Severe Traumatic Brain Injury. Journal of Neurotrauma, 41(21-22), 1-20.
DOI Scopus7 Europe PMC7
2024 Saywell, I., Foreman, L., Child, B., Phillips-Hughes, A. L., Collins-Praino, L., & Baetu, I. (2024). Influence of cognitive reserve on cognitive and motor function in α-synucleinopathies: A systematic review and multilevel meta-analysis. Neuroscience and Biobehavioral Reviews, 161, 28 pages.
DOI Scopus6 WoS6 Europe PMC4
2024 Carr, L. M., Mustafa, S., Care, A., & Collins-Praino, L. E. (2024). More than a number: Incorporating the aged phenotype to improve in vitro and in vivo modeling of neurodegenerative disease. Brain, Behavior, and Immunity, 119, 554-571.
DOI Scopus2 WoS2 Europe PMC2
2024 Child, B., Saywell, I., da Silva, R., Collins-Praino, L., & Baetu, I. (2024). Cognitive function in different motor subtypes of Parkinson's disease: A systematic review protocol.. Health Sci Rep, 7(5), e2092.
DOI Scopus2 WoS3 Europe PMC4
2024 Ponsford, J. L., Hicks, A. J., Bagg, M. K., Phyland, R., Carrier, S., James, A. C., . . . Vallmuur, K. (2024). The Australian Traumatic Brain Injury Initiative: Review and Recommendations for Outcome Measures for Use With Adults and Children After Moderate-to-Severe Traumatic Brain Injury. Neurotrauma Reports, 5(1), 387-408.
DOI Scopus5
2024 Antonic-Baker, A., Auvrez, C., Tao, G., Bagg, M. K., Gadowski, A., McKimmie, A., . . . Togher, L. (2024). The Australian Traumatic Brain Injury Initiative: Systematic Review and Consensus Process to Determine the Predictive Value of Pre-existing Health Conditions for People with Moderate-Severe Traumatic Brain Injury. Journal of Neurotrauma, 41(21-22), 1-15.
DOI Scopus3 Europe PMC5
2024 Boyton, I., Rennie, C., Collins-Praino, L. E., & Care, A. (2024). Nanoparticle Formulations for the Improvement of Symptomatic Treatments of Neurodegenerative Disorders. Chemnanomat, 10(12), 19 pages.
DOI Scopus1 WoS1
2023 Hood, R. J., Sanchez‐Bezanilla, S., Beard, D. J., Rust, R., Turner, R. J., Stuckey, S. M., . . . Ong, L. K. (2023). Leakage beyond the primary lesion: A temporal analysis of cerebrovascular dysregulation at sites of hippocampal secondary neurodegeneration following cortical photothrombotic stroke. Journal of Neurochemistry, 167(6), 733-752.
DOI Scopus3 WoS4 Europe PMC3
2023 Haller, O. J., Semendric, I., George, R. P., Collins-Praino, L. E., & Whittaker, A. L. (2023). The effectiveness of anti-inflammatory agents in reducing chemotherapy-induced cognitive impairment in preclinical models – a systematic review. Neuroscience & Biobehavioral Reviews, 148, 105120-1-105120-37.
DOI Scopus8 WoS6 Europe PMC5
2023 Semendric, I., Pollock, D., Haller, O., George, R., Collins-Praino, L., & Whittaker, A. (2023). "Chemobrain" in childhood cancer survivors - the impact on social, academic, and daily living skills: a qualitative systematic review. Supportive Care in Cancer, 31(9), 532-1-532-15.
DOI Scopus11 WoS9 Europe PMC5
2023 Saywell, I., Child, B., Foreman, L., Collins‐Praino, L., & Baetu, I. (2023). Influence of cognitive reserve on cognitive and motor function in α‐synucleinopathies: A systematic review protocol. Annals of the New York Academy of Sciences, 1522(1), 15-23.
DOI Scopus3 WoS3 Europe PMC2
2023 Corrigan, F., Arulsamy, A., Shultz, S. R., Wright, D. K., & Collins-Praino, L. E. (2023). Initial Severity of Injury Has Little Effect on the Temporal Profile of Long-Term Deficits in Locomotion, Anxiety, and Cognitive Function After Diffuse Traumatic Brain Injury. Neurotrauma Reports, 4(1), 41-50.
DOI Scopus5 WoS5 Europe PMC5
2023 Amro, Z., Ryan, M., Collins-Praino, L. E., & Yool, A. J. (2023). Unexpected Classes of Aquaporin Channels Detected by Transcriptomic Analysis in Human Brain Are Associated with Both Patient Age and Alzheimer’s Disease Status. Biomedicines, 11(3), 1-19.
DOI Scopus11 WoS11 Europe PMC11
2023 Corrigan, F., Wee, I. C., & Collins-Praino, L. E. (2023). Chronic motor performance following different traumatic brain injury severity-A systematic review. FRONTIERS IN NEUROLOGY, 14, 47 pages.
DOI Scopus26 WoS26 Europe PMC22
2022 Semendric, I., Pollock, D., Haller, O., George, R., Collins-Praino, L., & Whittaker, A. (2022). ‘‘Chemobrain’’ in childhood cancer survivors - the impact on social, academic, and daily living skills: a qualitative systematic review protocol. JBI Evidence Synthesis, 20(1), 222-228.
DOI Scopus3 WoS3 Europe PMC3
2022 Guglietti, B., Hobbs, D. A., Wesson, B., Ellul, B., McNamara, A., Drum, S., & Collins-Praino, L. E. (2022). Development and Co-design of NeuroOrb: A Novel "Serious Gaming" System Targeting Cognitive Impairment in Parkinson's Disease.. Frontiers in aging neuroscience, 14(728212), 1-18.
DOI Scopus6 WoS5 Europe PMC3
2021 Kaukas, L., Holmes, J. L., Rahimi, F., Collins-Praino, L., & Corrigan, F. (2021). Injury during adolescence leads to sex-specific executive function deficits in adulthood in a pre-clinical model of mild traumatic brain injury.. Behav Brain Res, 402, 1-14.
DOI Scopus10 WoS10 Europe PMC8
2021 El-Gamal, M., Salama, M., Collins-Praino, L. E., Baetu, I., Fathalla, A. M., Soliman, A. M., . . . Moustafa, A. A. (2021). Neurotoxin-Induced Rodent Models of Parkinson’s Disease: Benefits and Drawbacks. Neurotoxicity Research, 39(3), 827-923.
DOI Scopus28 WoS26 Europe PMC23
2021 Chin, H. Y., Lardelli, M., Collins-Praino, L., & Barthelson, K. (2021). Loss of park7 activity has differential effects on expression of iron responsive element (IRE) gene sets in the brain transcriptome in a zebrafish model of Parkinson's disease.. Mol Brain, 14(1), 83.
DOI Scopus9 WoS9 Europe PMC8
2021 Guglietti, B., Carr, L., Ellul, B., Mustafa, S., Corrigan, F., & Collins-Praino, L. (2021). Fyn kinase inhibition using AZD0530 improves recognition memory and reduces depressive-like behaviour in an experimental model of Parkinson’s disease.
DOI Europe PMC1
2021 Guglietti, B., Sivasankar, S., Mustafa, S., Corrigan, F., & Collins-Praino, L. E. (2021). Fyn Kinase Activity and Its Role in Neurodegenerative Disease Pathology: a Potential Universal Target?. Mol Neurobiol, 58(11), 5986-6005.
DOI Scopus34 WoS31 Europe PMC31
2021 Amro, Z., Yool, A. J., & Collins-Praino, L. E. (2021). The potential role of glial cells in driving the prion-like transcellular propagation of tau in tauopathies. Brain, behavior, & immunity - health, 14, 100242-1-100242-14.
DOI Scopus27 WoS24 Europe PMC23
2021 Guglietti, B., Hobbs, D., & Collins-Praino, L. E. (2021). Optimizing Cognitive Training for the Treatment of Cognitive Dysfunction in Parkinson's Disease: Current Limitations and Future Directions.. Front Aging Neurosci, 13(709484), 709484.
DOI Scopus19 WoS18 Europe PMC13
2021 Stuckey, S. M., Ong, L. K., Collins-Praino, L. E., & Turner, R. J. (2021). Neuroinflammation as a Key Driver of Secondary Neurodegeneration Following Stroke?. International Journal of Molecular Sciences, 22(23), 1-45.
DOI Scopus111 WoS107 Europe PMC102
2021 Boyton, I., Goodchild, S. C., Diaz, D., Elbourne, A., Collins-Praino, L. E., & Care, A. (2021). Characterizing the Dynamic Disassembly/Reassembly Mechanisms of Encapsulin Protein Nanocages. ACS OMEGA, 7(1), 823-836.
DOI Scopus21 WoS19 Europe PMC17
2021 Chin, H. Y., Lardelli, M., Collins-Praino, L., & Barthelson, K. (2021). Differential effects of loss of<i>park7</i>activity on Iron Responsive Element (IRE) gene sets: Implications for the role of iron dyshomeostasis in the pathophysiology of Parkinson’s disease.
DOI
2021 Sanchez-Bezanilla, S., Hood, R. J., Collins-Praino, L. E., Turner, R. J., Walker, F. R., Nilsson, M., & Ong, L. K. (2021). More than motor impairment: A spatiotemporal analysis of cognitive impairment and associated neuropathological changes following cortical photothrombotic stroke. Journal of Cerebral Blood Flow and Metabolism, 14(9), 2439-2455.
DOI Scopus31 WoS29 Europe PMC29
2021 Kaukas, L., Krieg, J., Collins-Praino, L., & Corrigan, F. (2021). Effects of Remote Immune Activation on Performance in the 5-Choice Serial Reaction Time Task Following Mild Traumatic Brain Injury in Adolescence. Frontiers in Behavioral Neuroscience, 15, 1-10.
DOI Scopus4 WoS4 Europe PMC4
2020 Gutteridge, D. S., Saredakis, D., Badcock, N. A., Collins-Praino, L. E., & Keage, H. A. D. (2020). Cerebrovascular function during cognition in Parkinson's disease: a functional transcranial Doppler sonography study. Journal of the Neurological Sciences, 408, 1-8.
DOI Scopus9 WoS8 Europe PMC10
2020 Sun, M., McDonald, S. J., Brady, R. D., Collins-Praino, L., Yamakawa, G. R., Monif, M., . . . Shultz, S. R. (2020). The need to incorporate aged animals into the preclinical modeling of neurological conditions. Neuroscience and Biobehavioral Reviews, 109, 114-128.
DOI Scopus39 WoS35 Europe PMC27
2020 Mohamed, A. Z., Corrigan, F., Collins-Praino, L. E., Plummer, S. L., Soni, N., & Nasrallah, F. A. (2020). Evaluating spatiotemporal microstructural alterations following diffuse traumatic brain injury. NeuroImage: Clinical, 25(102136), 15 pages.
DOI Scopus31 WoS28 Europe PMC23
2020 Sheynin, J., Baetu, I., Collins-Praino, L. E., Myers, C. E., Winwood-Smith, R., & Moustafa, A. A. (2020). Maladaptive avoidance patterns in Parkinson's disease are exacerbated by symptoms of depression. Behavioural Brain Research, 382, 112473-1-112473-9.
DOI Scopus4 WoS2 Europe PMC3
2020 Pardo, M., Paul, N. E., Collins-Praino, L. E., Salamone, J. D., & Correa, M. (2020). The non-selective adenosine antagonist theophylline reverses the effects of dopamine antagonism on tremor, motor activity and effort-based decision-making. Pharmacology Biochemistry and Behavior, 198, 1-11.
DOI Scopus15 Europe PMC11
2020 Iacopetta, K., Collins-Praino, L. E., Buisman-Pijlman, F., Liu, J., Hutchinson, A., & Hutchinson, M. R. (2020). Are the protective benefits of vitamin D in neurodegenerative disease dependent on route of administration? A systematic review. Nutritional Neuroscience, 23(4), 251-280.
DOI Scopus16 WoS15 Europe PMC13
2019 Collins-Praino, L. E., & Byard, R. W. (2019). Infants who die in shared sleeping situations differ from those who die while sleeping alone. Acta Paediatrica, International Journal of Paediatrics, 108(4), 611-614.
DOI Scopus20 WoS13 Europe PMC5
2019 Arulsamy, A., Corrigan, F., & Collins-Praino, L. E. (2019). Cognitive and neuropsychiatric impairments vary as a function of injury severity at 12 months post-experimental diffuse traumatic brain injury: implications for dementia development. Behavioural Brain Research, 365, 66-76.
DOI Scopus19 WoS16 Europe PMC16
2019 Arulsamy, A., Corrigan, F., & Collins-Praino, L. E. (2019). Age, but not severity of injury, mediates decline in executive function: validation of the rodent touchscreen paradigm for preclinical models of traumatic brain injury. Behavioural Brain Research, 368(article no. 111912), 1-14.
DOI Scopus6 WoS4 Europe PMC7
2019 Saredakis, D., Collins-Praino, L. E., Gutteridge, D. S., Stephan, B. C. M., & Keage, H. A. D. (2019). Conversion to MCI and dementia in Parkinson's disease: a systematic review and meta-analysis. Parkinsonism and Related Disorders, 65, 20-31.
DOI Scopus120 WoS115 Europe PMC92
2018 Collins-Praino, L. E., Gutschmidt, D., Sharkey, J., Arulsamy, A., & Corrigan, F. (2018). Temporal changes in tau phosphorylation and related kinase and phosphatases following two models of traumatic brain injury. Journal of Neuroinflammation and Neurodegenerative Disease, 2(1), 10007-1-10007-13.
2018 Collins-Praino, L., & Corrigan, F. (2018). Cerebrovascular contribution to dementia development after traumatic brain injury: promises and problems. Annals of translational medicine, 6(Suppl. 1), S58-1-S58-5.
DOI WoS3 Europe PMC2
2018 Iacopetta, K., Collins-Praino, L., Buisman-Pijlman, F., & Hutchinson, M. (2018). Can neuroimmune mechanisms explain the link between ultraviolet light (UV) exposure and addictive behavior?. Brain, Behavior, and Immunity, 73, 125-132.
DOI Scopus4 WoS4 Europe PMC5
2018 Collins-Praino, L., Arulsamy, A., Katharesan, V., & Corrigan, F. (2018). The effect of an acute systemic inflammatory insult on the chronic effects of a single mild traumatic brain injury. Behavioural Brain Research, 336, 22-31.
DOI Scopus40 WoS39 Europe PMC31
2018 Spinelli, J., Byard, R. W., Van Den Heuvel, C., & Collins-Praino, L. E. (2018). Medullary Astrogliosis in Sudden Infant Death Syndrome Varies With Sleeping Environment: Evidence for Different Mechanisms of Death in Alone Versus Co-sleepers?. Journal of child neurology, 33(4), 269-274.
DOI Scopus14 WoS10 Europe PMC4
2018 Arulsamy, A., Teng, J., Colton, H., Corrigan, F., & Collins-Praino, L. (2018). Evaluation of early chronic functional outcomes and their relationship to pre-frontal cortex and hippocampal pathology following moderate-severe traumatic brain injury. Behavioural Brain Research, 348, 127-138.
DOI Scopus25 WoS23 Europe PMC16
2017 Spinelli, J., Collins-Praino, L., Van Den Heuvel, C., & Byard, R. (2017). Evolution and significance of the triple risk model in sudden infant death syndrome. Journal of Paediatrics and Child Health, 53(2), 112-115.
DOI Scopus33 WoS25 Europe PMC19
2017 Corrigan, F., Arulsamy, A., Collins-Praino, L., Holmes, J., & Vink, R. (2017). Toll like receptor 4 activation can be either detrimental or beneficial following mild repetitive traumatic brain injury depending on timing of activation. Brain, Behavior, and Immunity, 64(3), 124-139.
DOI Scopus41 WoS37 Europe PMC30
2017 Corrigan, F., Arulsamy, A., Teng, J., & Collins-Praino, L. (2017). Pumping the Brakes: Neurotrophic Factors for the Prevention of Cognitive Impairment and Dementia after Traumatic Brain Injury. Journal of Neurotrauma, 34(5), 971-986.
DOI Scopus17 WoS16 Europe PMC8
2017 Collins-Praino, L., & Corrigan, F. (2017). Does neuroinflammation drive the relationship between tau hyperphosphorylation and dementia development following traumatic brain injury?. Brain, Behavior, and Immunity, 60, 369-382.
DOI Scopus81 WoS74 Europe PMC61
2014 Collins-Praino, L. E., Francis, Y. I., Griffith, E. Y., Wiegman, A. F., Urbach, J., Lawton, A., . . . Brickman, A. M. (2014). Soluble amyloid beta levels are elevated in the white matter of Alzheimer's patients, independent of cortical plaque severity.. Acta neuropathologica communications, 2(1), 1-10.
DOI Europe PMC53
2014 Brickman, A., Schupf, N., Manly, J., Stern, Y., Luchsinger, J., Provenzano, F., . . . Portet, F. (2014). APOE ε4 and risk for Alzheimer's disease: Do regionally distributed white matter hyperintensities play a role?. Alzheimer's and Dementia, 10(6), 619-629.
DOI Scopus65 WoS63 Europe PMC67
2014 Collins-Praino, L., Francis, Y., Griffith, E., Wiegman, A., Urbach, J., Lawton, A., . . . Brickman, A. (2014). Soluble amyloid beta levels are elevated in the white matter of Alzheimer's patients, independent of cortical plaque severity. Acta Neuropathologica Communications, 2(1), 83-1-83-10.
DOI Scopus62 WoS71
2013 Salamone, J., Collins-Praino, L., Pardo, M., Podurgiel, S., Baqi, Y., Muller, C., . . . Correa, M. (2013). Conditional neural knockout of the adenosine A₂A receptor and pharmacological A₂A antagonism reduce pilocarpine-induced tremulous jaw movements: studies with a mouse model of parkinsonian tremor. European Neuropsychopharmacology, 23(8), 972-977.
DOI Scopus25 WoS20 Europe PMC17
2013 Podurgiel, S., Collins-Praino, L., Yohn, S., Randall, P., Roach, A., Lobianco, C., & Salamone, J. (2013). Tremorolytic effects of safinamide in animal models of drug-induced parkinsonian tremor. Pharmacology Biochemistry and Behavior, 105, 105-111.
DOI Scopus30 WoS28 Europe PMC20
2013 Collins-Praino, L., Paul, N., Ledgard, F., Podurgiel, S., Kovner, R., Baqi, Y., . . . Salamone, J. (2013). Deep brain stimulation of the subthalamic nucleus reverses oral tremor in pharmacological models of parkinsonism: interaction with the effects of adenosine A2A antagonism. European Journal of Neuroscience, 38(1), 2183-2191.
DOI Scopus18 WoS16 Europe PMC13
2012 Santerre, J., Nunes, E., Kovner, R., Leser, C., Randall, P., Collins-Praino, L., . . . Salamone, J. (2012). The novel adenosine A2A antagonist prodrug MSX-4 is effective in animal models related to motivational and motor functions. Pharmacology, Biochemistry and Behavior, 102(4), 477-487.
DOI Scopus43 WoS40 Europe PMC32
2012 Collins-Praino, L., Podurgiel, S., Kovner, R., Randall, P., & Salamone, J. (2012). Extracellular GABA in globus pallidus increases during the induction of oral tremor by haloperidol but not by muscarinic receptor stimulation. Behavioural Brain Research, 234(1), 129-135.
DOI Scopus13 WoS12 Europe PMC11
2012 Collins-Praino, L., Sager, T., Sams, A., Pennarola, A., Port, R., Shahriari, M., & Salamone, J. (2012). The novel adenosine A₂A antagonist Lu AA47070 reverses the motor and motivational effects produced by dopamine D2 receptor blockade. Pharmacology Biochemistry and Behavior, 100(3), 498-505.
DOI Scopus37 WoS32 Europe PMC26
2011 Collins-Praino, L., Paul, N., Rychalsky, K., Hinman, J., Chrobak, J., Senatus, P., & Salamone, J. (2011). Pharmacological and physiological characterization of the tremulous jaw movement model of parkinsonian tremor: potential insights into the pathophysiology of tremor. Frontiers in Systems Neuroscience, 5(JULY 2011), 49:1-49:14.
DOI Scopus33 WoS30 Europe PMC25
2011 Collins-Praino, L., Paul, N., Abbas, S., Leser, C., Podurgiel, S., Galtieri, D., . . . Salamone, J. (2011). Oral tremor induced by galantamine in rats: a model of the parkinsonian side effects of cholinomimetics used to treat Alzheimer's disease. Pharmacology Biochemistry and Behavior, 99(3), 414-422.
DOI Scopus29 WoS29 Europe PMC20
2010 Sink, K., Segovia, K., Sink, J., Randall, P., Collins-Praino, L., Correa, M., . . . Salamone, J. (2010). Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142. European Neuropsychopharmacology, 20(2), 112-122.
DOI Scopus73 WoS71 Europe PMC61
2010 Collins-Praino, L., Galtieri, D., Brennum, L., Sager, T., Hockemeyer, J., Muller, C., . . . Salamone, J. (2010). Oral tremor induced by the muscarinic agonist pilocarpine is suppressed by the adenosine A2A antagonists MSX-3 and SCH58261, but not the adenosine A1 antagonist DPCPX. Pharmacology Biochemistry and Behavior, 94(4), 561-569.
DOI Scopus37 WoS33 Europe PMC23
2010 Collins-Praino, L., Galtieri, D., Collins, P., Jones, S., Port, R., Paul, N., . . . Salamone, J. (2010). Interactions between adenosine and dopamine receptor antagonists with different selectivity profiles: effects on locomotor activity. Behavioural Brain Research, 211(25), 148-155.
DOI Scopus46 WoS43 Europe PMC36
2010 Farrar, A., Segovia, K., Randall, P., Nunes, E., Collins-Praino, L., Stopper, C., . . . Salamone, J. (2010). Nucleus accumbens and effort-related functions: behavioral and neural markers of the interactions between adenosine A2A and dopamine D2 receptors. Neuroscience, 166(4), 1056-1067.
DOI Scopus99 WoS97 Europe PMC86
2010 Sink, K., Segovia, K., Collins-Praino, L., Markus, E., Vemuri, V., Makriyannis, A., & Salamone, J. (2010). The CB1 inverse agonist AM251, but not the CB1 antagonist AM4113, enhances retention of contextual fear conditioning in rats. Pharmacology Biochemistry and Behavior, 95(4), 479-484.
DOI Scopus39 WoS37 Europe PMC32
2010 Salamone, J., Correa, M., Farrar, A., Nunes, E., & Collins-Praino, L. (2010). Role of dopamine-adenosine interactions in the brain circuitry regulating effort-related decision making: insights into pathological aspects of motivation. Future Neurology, 5(3), 377-392.
DOI Scopus32 WoS32
2009 Mott, A., Nunes, E., Collins-Praino, L., Port, R., Sink, K., Hockemeyer, J., . . . Salamone, J. (2009). The adenosine A2A antagonist MSX-3 reverses the effects of the dopamine antagonist haloperidol on effort-related decision making in a T-maze cost/benefit procedure. Psychopharmacology, 204(1), 103-112.
DOI Scopus95 WoS87 Europe PMC83
2009 Salamone, J., Farrar, A., Font, L., Patel, V., Schlar, D., Nunes, E., . . . Sager, T. (2009). Differential actions of adenosine A₁ and A₂A antagonists on the effort-related effects of dopamine D₂ antagonism. Behavioural Brain Research, 201(1), 216-222.
DOI Scopus83 WoS79 Europe PMC69
2009 Sink, K., Segovia, K., Nunes, E., Collins-Praino, L., Vemuri, V., Thakur, G., . . . Salamone, J. (2009). Intracerebroventricular administration of cannabinoid CB1 receptor antagonists AM251 and AM4113 fails to alter food-reinforced behavior in rats. Psychopharmacology, 206(2), 223-232.
DOI Scopus22 WoS22 Europe PMC19
2006 Collins, L. E., & Waldeck, R. F. (2006). Telencephalic ablation results in decreased startle response in goldfish. Brain Research, 1111(1), 162-165.
DOI Scopus3 WoS3 Europe PMC1

Year Citation
2022 Collins-Praino, L. E. (2022). Traumatic axonal injury as a key driver of the relationship between traumatic brain injury, cognitive dysfunction, and dementia. In R. Rajendram,, V. R. Preedy, & C. R. Martin (Eds.), Cellular, Molecular, Physiological, and Behavioral Aspects of Traumatic Brain Injury (pp. 475-486). United Kingdom: Academic Press.
DOI Scopus2
2020 Foreman, L. M., Baetu, I., Rego, J., Collins-Praino, L., & Moustafa, A. (2020). Theories of compulsive drug use: A brief overview of learning and motivation processes. In A. Moustafa (Ed.), Cognitive, Clinical, and Neural Aspects of Drug Addiction (pp. 137-185). London, United Kingdom: Academic Press.
DOI Scopus2
2014 Salamone, J., Podurgiel, S., Collins-Praino, L., & Correa, M. (2014). Physiological and behavioral assessment of tremor in rodents. In M. LeDoux (Ed.), Movement Disorders: Genetics and Models (2 ed., pp. 631-640). Elsevier.
DOI Scopus2

Year Citation
2024 Collins-Praino, L., McNamara, A., Ellul, B., Baetu, I., Lau, S., & Jenkinson, M. (2024). Beyond Clinical Presentation: Incorporating Neuroimaging and Biofluid Markers to Predict Progression of Parkinson's disease (PD). In MOVEMENT DISORDERS Vol. 39 (pp. S63-S64). PA, Philadelphia: WILEY.
2024 Stuckey, S. M., Collins-Praino, L. E., Costigan-Dwyer, R. A., Bilecki, I. M., Homes-Vickers, M. A., Poyzer, A. J., . . . Turner, R. J. (2024). The role of neuroinflammation in delayed neurodegeneration following photothrombotic stroke in rats. In Abstracts of the Asia Pacific Stroke Conference Combined Australian and New Zealand Stroke Organisation Conference (2024) as published in Cerebrovascular Diseases Vol. 53 (pp. 30). Adelaide, Australia: Karger Publishers.
2017 Collins-Praino, L., Burton, J., & Johnson, I. (2017). Integration of a novel three-dimensional teaching tool for undergraduate neuroanatomy: student opinions and learning outcomes.. In Journal of Anatomy Vol. 230 (pp. 358). Sussex, UK: Blackwell Publishing Inc..

Year Citation
2024 Gecz, J., Bhattacharjee, R., Palmer, E., Gardner, A., Carroll, R., Wee, I. C., . . . Kumar, R. (2024). Genetic, Molecular and Mouse Model Investigations of Neurodevelopmental Impact of Deleterious Variants of the TREX Transcription-mRNA Export Complex Subunits. Poster session presented at the meeting of Abstracts of the 57th European Society of Human Genetics Conference (ESHG 2024), as published in European Journal of Human Genetics. Berlin, Germany: Springer Nature.
DOI
2023 Ellul, B., McNamara, A., Baetu, I., Lau, S., Jenkinson, M., & Collins-Praino, L. (2023). Predicting longitudinal cognition and mood changes in newly diagnosed Parkinson's Disease from substantia nigra imaging (Oral Presentation). Poster session presented at the meeting of ACNS Conference Sydney 2023. https://drive.google.com/drive/folders/1Ixovo4O6LZNfSrf4S0Ds6vkbmyayHHEt.
2023 McNamara, A., Ellul, B., Baetu, I. -I., Lau, S., Jenkinson, M., & Collins-Praino, L. (2023). Utility of Baseline Pathological, Neuroimaging and Clinical Markers for Progression Prognosis and Subtype Classification in Early Parkinson's Disease: Implications for Cognitive Impairment. Poster session presented at the meeting of Abstracts of the Alzheimer's Association International Conference (AAIC 2023), as published in Alzheimer's & Dementia Journal. Amsterdam, The Netherlands: Wiley.
DOI
2023 McNamara, A., Ellul, B., Baetu, I. -I., Lau, S., Jenkinson, M., & Collins-Praino, L. (2023). Predicting progression of Parkinson’s disease motor outcomes using a multimodal combination of baseline clinical measures, neuroimaging and biofluid markers. Poster session presented at the meeting of Abstracts of the 6th World Parkinson Congress, as published in Journal of Parkinson's Disease. Barcelona, Spain: IOS Press.
DOI
2022 McNamara, A., Ellul, B., Baetu, I., Lau, S., Jenkinson, M., & Collins-Praino, L. (2022). Predicting Progression of Parkinson’s Disease Motor Outcomes Using a Multimodal Combination of Baseline Clinical Measures, Neuroimaging and Biofluid Markers in Early PD. Poster session presented at the meeting of Australasian Neuroscience Conference 2022. Melbourne.
2022 Ellul, B., McNamara, A., Baetu, I., Lau, S., Jenkinson, M., & Collins-Praino, L. (2022). The role of the substantia nigra in predicting longitudinal cognitive and mood changes in newly diagnosed Parkinson’s Disease. Poster session presented at the meeting of Australasian Neuroscience Conferences 2022. Melbourne, Australia.
2019 Child, B. D., Baetu, I., Collins-Praino, L., & Burns, N. (2019). Reinforcement learning in Parkinson’s disease: Do motor symptoms predict performance?. Poster session presented at the meeting of 28th Annual Meeting of the International Behavioral Neuroscience Society. Cairns, Australia.
2019 Corrigan, F., Kaukas, L., Collins-Praino, L., & Holmes, J. (2019). EFFECT OF A MILD TRAUMATIC BRAIN INJURY DURING ADOLESCENCE ON EXECUTIVE FUNCTION IN ADULTHOOD. Poster session presented at the meeting of JOURNAL OF NEUROTRAUMA. Pittsburgh, PA: MARY ANN LIEBERT, INC.
2019 Child, B. D., Baetu, I., Collins-Praino, L., Salamon, J., & Burns, N. (2019). Reinforcement learning in Parkinson's disease: Do motor symptoms predict performance?. Poster session presented at the meeting of Florey Postgraduate Research Conference. Adelaide, Australia.
2018 Johnson, I., Collins-Praino, L., & Burton, J. (2018). They liked it, but did they learn anything?. Poster session presented at the meeting of Clinical Anatomy. Canberra, Australia: Wiley.
2016 Collins-Praino, L., Teng, J., Colton, H., Van den Heuvel, C., & Corrigan, F. (2016). INVESTIGATING THE COMPLEX RELATIONSHIP BETWEEN NEUROINFLAMMATION, NEURODEGENERATION AND LONG-TERM FUNCTIONAL OUTCOMES IN AN EXPERIMENTAL MODEL OF TRAUMATIC BRAIN INJURY. Poster session presented at the meeting of JOURNAL OF NEUROTRAUMA. Cape Town, SOUTH AFRICA: MARY ANN LIEBERT, INC.
2016 Corrigan, F., & Vink, R. (2016). Toll like receptor 4 activation can be either detrimental or beneficial following mild repetitive traumatic brain injury depending on timing of activation. Poster session presented at the meeting of Abstracts of the 12th Symposium of the International Neurotrauma Society, as published in Journal of Neurotrauma. Cape Town, SOUTH AFRICA: Mary Ann Liebert.
DOI
2015 Collins-Praino, L., Burton, J., & Johnson, I. P. (2015). Evaluation of the utility of an in-house three-dimensional teaching tool for undergraduate neuroanatomy. Poster session presented at the meeting of Abstracts presented at the Australian and New Zealand Association of Clinical Anatomists (ANZACA) 11th annual meeting, “Anatomy in work and play,” 3rd to 5th December 2014, Queenstown, Otago, New Zealand, as published in Clinical Anatomy. Queenstown, New Zealand: Wiley.
DOI
2012 Collins‐Praino, L., Scarmeas, N., Manly, J., Schupf, N., Noble, J., Provenzano, F., . . . Brickman, A. (2012). P3‐193: White matter hyperintensities may mediate the relationship between inflammation and cognition in an elderly cohort. Poster session presented at the meeting of Alzheimer's &amp; Dementia. Wiley.
DOI

Year Citation
2021 Haller, O., Whittaker, A., George, R., Semendric, I., & Collins-Praino, L. (2021). Investigating the effects of anti-inflammatory agents in pre-clinical models of chemotherapy-induced cognitive impairment – a systematic review protocol. PROSPERO- registration no: CRD42021240789.
2021 Semendric, I., Haller, O., George, R., Pollock, D., Whittaker, A., & Collins-Praino, L. (2021). Experience of the impact of chemobrain in childhood cancer survivors: a qualitative systematic review protocol. PROSPERO 2021 CRD42021240573. PROSPERO.

Year Citation
2024 Green, A., Cowell, E., Carr, L., Hemsley, K., Sherratt, E., Collins-Praino, L., & Carr, J. (2024). Application of diceCT to Study the Development of the Zika Virus Infected Mouse Brain.
DOI
2024 Haller, O., Semendric, I., Collins-Praino, L., Whittaker, A., & George, R. (2024). Changes in cognition and neuroinflammation in a rodent model of chemotherapy-induced cognitive impairment are variable both acutely and chronically.
DOI

Since 2014, I have received over $1.5 million in competitive research funding. Funding bodies include the Australian Research Council (ARC), Neurosurgical Research Foundation, James and Diana Ramsay Foundation, Brain Foundation, the Australia-Japan Foundation, Perpetual IMPACT Philanthropy Application Program and Adelaide Research and Innovation.

 

 

Prior to coming to the University of Adelaide, I taught neuroscience, psychology and anatomy courses at the University of Connecticut (Storrs, CT, USA), Fairfield University (Fairfield, CT, USA) and Eastern Connecticut State University (Willimantic, CT, USA).

At the University of Adelaide, I currently teach into a number of courses in the Bachelors of Health and Medical Sciences, including:

  • Foundations of Human Neuroanatomy (Coordinator)
  • Essentials of Neuroscience (Co-Coordinator)
  • Neurological Diseases
  • Essential Understanding of Disease and Treatment
  • Ethics, Science and Society
  • Exercise, Movement and Cognition

In addition to my teaching duties in the Bachelor of Health and Medical Sciences program, I provide a large portion of neuroanatomy content across Years 1-3 of the MBBS program.

I am Co-Convenor of the Neuroscience major in the Bachelor of Health and Medical Science program.

Date Role Research Topic Program Degree Type Student Load Student Name
2025 Co-Supervisor Defining actions of complement to identify pan-therapeutic targets in traumatic brain injury Doctor of Philosophy Doctorate Full Time Miss Eloise Joy Arthur
2023 Principal Supervisor Changing the "Game" - Assessing cognitive function and the role of cognitive training in Parkinson's disease and Spinal Cord Injury. Doctor of Philosophy Doctorate Full Time Ms Madeleine Anne Homes-Vickers
2022 Co-Supervisor Development of a New Cognitive Reserve Measure: Implications for Parkinson’s Disease and Traumatic Brain Injury Doctor of Philosophy Doctorate Full Time Mr Isaac Calvin Saywell
2021 Principal Supervisor Chemobrain impact and remediation: a focus on the paediatric patient Doctor of Philosophy Doctorate Part Time Miss Ines Semendric
2021 Co-Supervisor COVID-19 related cognitive impairment: Underlying mechanisms and protective factors Doctor of Philosophy Doctorate Part Time Ms Lauren Mary Heidenreich
2019 Co-Supervisor An Exploration of the Role of Working Memory in Associative Learning Doctor of Philosophy Doctorate Part Time Miss Brittany Dorothy Amelia Child

Date Role Research Topic Program Degree Type Student Load Student Name
2022 - 2025 Principal Supervisor Understanding the Role of Environmental Exposures in Parkinson’s Disease: Synergistic Effects of Traumatic Brain Injury in Combination with Additional Risk Factors on the Nigrostriatal and Olfactory Systems Doctor of Philosophy Doctorate Full Time Ms Samantha Elizabeth Edwards
2021 - 2025 Co-Supervisor A multi-faceted approach to explore the role of neuroinflammation in chemotherapy-induced cognitive impairment: From systematic review to in vitro and in vivo modelling Doctor of Philosophy Doctorate Full Time Miss Olivia Jane Haller
2021 - 2025 Principal Supervisor Prediction of cognitive and mood trajectories and clinical awareness of neurodegenerative disease risk following traumatic brain injury Doctor of Philosophy Doctorate Full Time Mr Benjamin Paul Ellul
2021 - 2025 Principal Supervisor Bridging the Gap Between Parkinson’s Disease and Traumatic Brain Injury: The Role of Biological Assessments for Early Detection of Neurodegenerative Disease Risk and Prognosis of Clinical Outcomes Doctor of Philosophy Doctorate Full Time Mr Angus McNamara
2021 - 2025 Principal Supervisor Exploring Microglial Ageing: Insights from Human Genomic Data, Pre-Clinical Animal Models, and the Future of In Vitro Modelling Doctor of Philosophy Doctorate Full Time Miss Laura May Carr
2020 - 2025 Co-Supervisor Characterising the Role of Neuroinflammation in Delayed Neurodegeneration Following Ischemic Stroke in a Long-Term Rodent Model Doctor of Philosophy Doctorate Part Time Dr Shannon Mikayla Stuckey
2020 - 2025 Co-Supervisor Beyond the Spine: Investigating Chronic Cognitive Dysfunction Following Traumatic Spinal Cord Injury Doctor of Philosophy Doctorate Part Time Miss Kavi Sivasankar
2020 - 2023 Co-Supervisor Discovery of novel aquaporin subtypes in the human brain: Potential relevance of peroxiporins AQP0 and AQP11 to cellular stress and Alzheimer’s Disease Doctor of Philosophy Doctorate Full Time Mr Zein Alabedyn Amro
2020 - 2024 Principal Supervisor Investigating the impact of individual differences and stress on decision-making performance under threat Master of Philosophy (Medical Science) Master Part Time Mr Manuel Salazar
2019 - 2024 Principal Supervisor Exploring the Behavioural and Brain Basis of the Link Between Traumatic Brain Injury and Parkinson’s disease Doctor of Philosophy Doctorate Full Time Miss Ing Chee Wee
2019 - 2024 Co-Supervisor Characterising changes to the Blood-Brain Barrier in Healthy Ageing and Following Stroke in an Aged Preclinical Model Doctor of Philosophy Doctorate Part Time Dr Isabella Megan Bilecki
2019 - 2019 Co-Supervisor Peripheral-to-Central Neuroimmune Communication and the Sun: Implications for Addiction and Neurodegenerative Disease Pathology Master of Philosophy (Medical Science) Master Full Time Ms Krystal Lee Iacopetta
2017 - 2021 Principal Supervisor Targeting Cognitive Impairment in Parkinson’s Disease: Novel Pharmacological and Non-Pharmacological Approaches Doctor of Philosophy Doctorate Full Time Miss Bianca Laura Guglietti
2015 - 2019 Principal Supervisor From Trauma to Neurodegeneration: A One-Year Time Progression of Functional Impairments and its Associated Neuropathological Link Following Varied Severity of Experimental Diffuse Traumatic Brain Injury Doctor of Philosophy Doctorate Full Time Miss Alina Arulsamy

Date Role Committee Institution Country
2016 - ongoing Member School of Medicine (SOM) Early/Middle Career Researcher Committee University of Adelaide -
2016 - ongoing Treasurer National Science Week Committee (South Australia) - -
2016 - ongoing Member Inspiring South Australia Steering Group - -
2015 - ongoing Chair Year 1 MBBS Committee University of Adelaide -
2015 - ongoing Member MBBS Assessment Committee University of Adelaide -
2015 - ongoing Member Low-Risk Human Research Ethics Committee University of Adelaide -
2015 - ongoing Member MBBS Curriculum Committee Member - -
2015 - 2015 Member School of Medical Sciences Learning and Teaching Committee Member University of Adelaide -
2015 - 2015 Member School of Medical Sciences Seminar Committee University of Adelaide -

Date Role Membership Country
2016 - ongoing - Australasian Cognitive Neuroscience Society -
2016 - ongoing - International Neurotrauma Society -
2015 - ongoing - International Society for Neurochemistry -
2015 - ongoing - Australasian Neuroscience Society -
2006 - ongoing Member Society for Neuroscience -
2006 - ongoing Member International Basal Ganglia Society -

Date Office Name Institution Country
2016 - ongoing Co-convenor, Neuroscience Major University of Adelaide -
2015 - ongoing Year 1 Convenor, MBBS Program University of Adelaide -

Connect With Me

External Profiles